The SCOTUS reinstated a requirement that women visit a hospital or clinic to obtain a drug used for medication-induced abortions. The ruling granted a request by the Trump administration to lift a lower court’s order that had suspended the FDA rule requiring in-person visits, allowing the drug to be posted or delivered.